SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Extraordinary claims require extraordinary evidence · Study

ArticleShelves

ArticleExtraordinary claims require extraordinary evidence

Donald W. Light2005

Article2005

Extraordinary claims require extraordinary evidence

Donald W. Light · Rebecca Warburton

82 citations·0/0 files stored·Journal of Health Economics

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Intellectual Property and Patents Intellectual Property Law Pharmaceutical Economics and Policy

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 82 citations exist upstream.

References

2003The price of innovation: new estimates of drug development costs 1991Cost of innovation in the pharmaceutical industry

Cited by

2009Spending on new drug development1 2011US biopharmaceutical finance and the sustainability of the biotech business model 2011US Biopharmaceutical Finance and the Sustainability of the Biotech Business Model 2015The Cost of Drug Development 2008Pharmaceutical pricing policies in a global market 2008Pharmaceutical Pricing Policies in a Global Market 2005Spending on New Drug Development 2008Enabling TRIPs: The pharma–biotech–university patent coalition

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2016Essential medicines for universal health coveragereview · 2 shared references 2007The cost of biopharmaceutical R&D: is biotech different?article · 2 shared references 2011The cost of drug development: A systematic reviewreview · 2 shared references 2004Key factors in the rising cost of new drug discovery and developmentreview · 2 shared references 2021How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessmentreview · 2 shared references 2007Economics of New Oncology Drug Developmentarticle · 2 shared references

Details

Year2005

Typearticle

Published2005-08-09

VenueJournal of Health Economics

ISSN-L0167-6296

Languageen

Citations82

Files0 public / 0

ShelfIntellectual Property and Patents

Identifiers

doi10.1016/j.jhealeco.2005.07.001

openalex_workW2138404206

Links

Imported from OpenAlex (CC0) — nothing here is generated.